BR101 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07537049 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07537049
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2027-04-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.